NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index; 13 of the 27 sources its claims cite were checked for support.
Abstract
Here we show that nicotinamide riboside kinase 1 (NRK1) is necessary and rate-limiting for the use of exogenous NR and NMN for NAD+ synthesis. Using stable isotope-labelled compounds, we confirm NMN is metabolized extracellularly to NR that is then taken up by the cell and converted into NAD+.
Overview
CoChat Summary
## TL;DR
NRK1 is the key rate-limiting enzyme that mammalian cells and liver require to convert exogenous nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) into NAD+. The paper shows that NMN is first dephosphorylated extracellularly to NR, which is then taken up and used for NAD+ synthesis.
## Key findings
- In NIH/3T3 cells, overexpression of active NRK1 or NRK2 converted NR-nonresponsive cells into NR-responsive cells, producing about a 4-fold increase in NAD+; catalytically inactive NRK1-D36A and NRK2-D35A did not.
- In F3T3-NRK1 cells, NR increased NAD+ at concentrations as low as 100 μM, with maximal effects at about 1 mM; NMN increased NAD+ only in NRK1-overexpressing cells and less potently than NR, while NAM worked regardless of NRK1.
- In primary hepatocytes from NRK1KO mice, NR and NMN failed to increase NAD+, whereas NA and NAM still increased NAD+ normally.
- In vivo, 500 mg kg−1 intraperitoneal NR raised liver NAD+ by about 220% in wild-type mice; NMN and NAM raised it by about 170%, and NR/NMN responses were significantly blunted in NRK1KO mice, though about 60% of the NR and NMN effect remained.
## Methods
- The study used gain- and loss-of-function models: transient and stable NRK1/NRK2 overexpression in cell lines, siRNA knockdown of Nmrk1 in AML12 hepatocytes, and a constitutive Nmrk1 knockout mouse.
- NAD+ precursor metabolism was tested in cultured cells, primary hepatocytes, primary brown adipocytes, and mice using NR, NMN, NAM, and NA treatments, plus isotope-labeled compounds for flux analysis.
- Main analyses included NAD+ quantification by assay, targeted LC-MS/LC-QqQ MS metabolomics, western blotting, and qPCR; statistical testing used t-tests or one-way ANOVA with Bonferroni post-test.
## Limitations
- The paper states that data are available only upon request, which limits immediate reproducibility access.
- The text makes evident that several mechanistic claims rely on high-dose precursor injections in mice (e.g., 500 mg kg−1 and 50 mg kg−1), so some in vivo effects may not reflect physiological exposure; this is evident from the text.
- The paper itself notes that future work is needed to better characterize circulating NAD+, NMN, and NR and to optimize organ-targeted formulations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Extracellular NMN dephosphorylates to NR. HepG2 cells were treated with [18O]-labelled NR (a,b) or NMN (c,d). Intracellular enrichment of labelled compounds (a,c) and presence of labelled compounds in the media of treated cells (b,d). Results shown are mean±s.e.m. (n=3).](https://figures.cochat.ai/paper-figures/57e8a39cf3da45969cbff31a92059db8/nrk1-controls-nicotinamide-mononucleotide-and-nicotinamide-riboside-metabolism-figure-4.jpg)

![Figure 6 Extracellular conversion of NMN to NR by hepatocytes. (a) Primary hepatocytes were isolated from 10 to 15 weeks old WT mice. Cells were treated with 2 μM FK866 and ±2 mM CMP for 1 h. Then, 0.5 mM NR or NMN was added and NAD+ was measured after 2 h. (b,c) WT (b) and NRK1KO (c) hepatocytes were treated with [2H]-[13C]-double labelled NR or NMN. Intracellular enrichment of labelled compounds. Results shown are mean±s.e.m., **P<0.01 versus ctrl by two-sided unpaired T-test (n=3).](https://figures.cochat.ai/paper-figures/d72a2197ccbc48f5bcf199a67d302e52/nrk1-controls-nicotinamide-mononucleotide-and-nicotinamide-riboside-metabolism-figure-6.jpg)


Verification
Claims the paper makes
12 Valid · 1 Not valid · 12 Not checked · 97 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Whereas NMN concentration has been reported to reach around 50 μM in plasma14, our study and others13 have failed to detect comparable levels of circulating NMN.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Not checked — no full text of the sourcecites [14] Revollo, J. R. et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6, 363–375 (2007). source
- Supportedcites [13] Hara, N., Yamada, K., Shibata, T., Osago, H. & Tsuchiya, M. Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma. PLoS ONE 6, e22781 (2011). source
The Results section reports that NMN was not detected in freshly prepared mouse plasma by LC/MS/MS, with a detection limit of 50 nM—far below the approximately 50 µM level mentioned in the citing sentence. The Discussion likewise contrasts this nondetection with earlier reports of high plasma NMN concentrations. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In line with this, CD73 silencing blocks the use of NMN as an extracellular NAD+ precursor17.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Partly supportedcites [17] Sociali, G. et al. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model. Oncotarget 7, 2968–2984 (2015). sourceExperimental — accuracy not yet measured
The Results section (Figure 2D) reports that CD73 silencing reduced by 70% the ability of FK866-treated OVCAR-3 cells to generate intracellular NAD+ from extracellular NMN. This supports impaired use of NMN, but not the claim that silencing completely blocks it. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, the induction of NRK2 in response to cellular damage or stress32 suggests the existence of a demand for circulating NR.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Supportedcites [32] Sasaki, Y., Araki, T. & Milbrandt, J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J. Neurosci. 26, 8484–8491 (2006). source
The Results section, “Expression of enzymes involved in NAD biosynthesis is induced in response to neuronal injury” (page not provided), reports that Nrk2 expression rose more than 20-fold after axotomy. The Discussion interprets this as part of the neuronal response to stress. The sentence’s suggestion of demand for circulating NR is the citing authors’ inference, not a finding it attributes to this source. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This experiment, conducted in parallel with a human clinical trial at the same effective dose of NR, showed that NR produces the greatest rise in liver NAD+ synthesis, followed by NAM and NA24.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Supportedcites [24] Trammell, S. A. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016). source
The Results section ('NR is the superior hepatic NAD+ precursor vitamin'; page not supplied) says the mouse dose was chosen to be comparable, after body-size adjustment, to an effective human NR dose, and that mice received NR or equimolar NAM and NA. The Discussion (page not supplied) ranks their effects on mouse liver NAD+ as NR, then NAM, then NA. The paper also reports a human clinical trial; it does not establish that the mouse experiment and trial ran at the same time. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, WT mice and NRK1/NRK2DKO displayed comparable increases in NAD+ levels in skeletal muscle after intraperitoneal NR and NMN administration (Supplementary Fig. 3d).”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Results > NRK1KO mice are deficient in NR and NMN utilization in vivo
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 122 claims and every source verdict.
- Probably not a substantial claim. 25
- It may state two separate claims as one. 49
- Borderline: one of the tests for a substantial claim is unclear. 1
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experimental evidence suggests that blood NA and NAM are able to cross the plasma membrane, while blood NAD+ cannot be taken up by cells directly but needs to be converted to smaller uncharged molecules to enter the cells (Hara et al., 2007; Ratajczak et al., 2016).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Ratajczak et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a previous study, the deficiency of NRK1, which phosphorylates NR to NMN, diminished the increase of NAD+ levels in the liver after oral NMN administration, suggesting that NMN was converted to NR before absorption (11).”
From Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD + synthesis via enterohepatic circulation (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Meanwhile, NR is converted to NMN by NR kinase (NRK), thereby bypassing the NAMPT-mediated step (11, 12).”
From Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD + synthesis via enterohepatic circulation (2025) · cites this paper as [11]
In the citing paper
“Additionally, nicotinamide riboside (NR) integrates in this pathway via the conversion of NR into NMN by nicotinamide riboside kinase 1 (NRK1) or NRK2 (Bieganowski and Brenner, 2004; Ratajczak et al., 2016).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Ratajczak et al., 2016
Citations
Cites
HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS
Berry, M. N., & Friend, D. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.43.3.506 · Cited by 4,424
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085 · cited 1×
“Importantly, sirtuin activation has been associated with an improvement in metabolic efficiency and healthspan in mammals 4,5 .”
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008
Self-citationCantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Self-citationGomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Self-citationCantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Self-citationMouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210
Self-citation
Cited by
Items 101–200 of 365
Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism
Klimova, N., & Kristián, T. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02729-0 · Cited by 44
Wang, Y.-J., Paneni, F., Stein, S., & Matter, C. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.755060 · Cited by 52
NAD+ Precursors: A Questionable Redundancy
Cantó, C. (2022) · Metabolites · doi:10.3390/metabo12070630 · Cited by 44
Self-citationNicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Bhasin, S., Seals, D. R., Migaud, M. E., Musi, N., & Baur, J. A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad019 · Cited by 54
Self-citationLi, W., Zhou, Y., Pang, N., Hu, Q., Li, Q., Sun, Y., Ding, Y., Gu, Y., Xiao, Y., Gao, M., et al. (2022) · Nutrients · doi:10.3390/nu15010174 · Cited by 42
“NR is converted to nicotinamide mononucleotide (NMN) via nicotinamide ribose kinase (NRK), and then to NAD via nicotinamide mononucleotide adenylyl transferase (NMNAT) [24].”
MethodYaku, K., Palikhe, S., Iqbal, T., Hayat, F., Watanabe, Y., Fujisaka, S., Izumi, H., Yoshida, T., Karim, M., Uchida, H., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr1538 · Cited by 40
“A previous study proposed that orally administered NR was directly absorbed from the intestine as an intact form and converted to NMN by NRK inside cells ( 11 , 60 ).”
Self-citationTannous, C., Deloux, R., Karoui, A., Mougenot, N., Burkin, D. J., Blanc, J., Coletti, D., Lavery, G. G., Li, Z., & Mericskay, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073534 · Cited by 46
“Similarly, there was no reduction in tissue NAD levels in the mice knocked out for the ubiquitously expressed gene Nmrk1, as measured in the liver, brown adipose tissue (BAT), kidney and skeletal muscles [35] nor was there any reduction in NAD levels in the skeletal muscles of Nmrk1/Nmrk2 double Ko mice [20].”
BackgroundBalancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
Cercillieux, A., Ciarlo, E., & Cantó, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04499-5 · Cited by 42
Self-citationHost–microbiome interactions in nicotinamide mononucleotide (NMN) deamidation
Kim, L., Chalmers, T. J., Madawala, R., Smith, G. C., Li, C., Das, A., Poon, E. W. K., Wang, J., Tucker, S. P., Sinclair, D. A., et al. (2023) · FEBS Letters · doi:10.1002/1873-3468.14698 · Cited by 41
(2020) · doi:10.1101/2020.09.10.289561 · Cited by 41
Effect of NAD+ boosting on kidney ischemia-reperfusion injury
Morevati, M., Egstrand, S., Nordholm, A., Mace, M. L., Andersen, C. B., Salmani, R., Ølgaard, K., & Lewin, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252554 · Cited by 47
“Furthermore, NR has been shown to be more efficient in boosting NAD than other NAD precursors such as NAM [83,84], possibly due to increased intestinal uptake [85,86].”
BackgroundA systems-approach to NAD+ restoration
Conlon, N. J., & Ford, D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114946 · Cited by 47
Maric, T., Bazhin, A. A., Khodakivskyi, P. V., Mikhaylov, G., Solodnikova, E. S., Yevtodiyenko, A., Attianese, G. M. P. G., Coukos, G., Irving, M. B., Joffraud, M., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114826 · Cited by 45
Self-citationBignon, Y., Wigger, L., Ansermet, C., Weger, B. D., Lagarrigue, S., Centeno, G., Durussel, F., Götz, L., Ibberson, M. R., Pradervand, S., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci167133 · Cited by 42
“While the quantitative role of NRK1 in NAD + production in the kidney remains unknown, this enzyme is expressed at high levels in the renal proximal tubule (36).”
Biţă, A., Scorei, I. R., Ciocîlteu, M. V., Nicolaescu, O. E., Pîrvu, A. S., Bejenaru, L. E., Rău, G., Bejenaru, C., Radu, A., Neamţu, J., et al. (2023) · Molecules · doi:10.3390/molecules28166078 · Cited by 36
“Simultaneous PNP downregulation could improve the health advantages of NRS [14,238].”
BackgroundMitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity
Dall, M., Trammell, S. A. J., Asping, M., Hassing, A. S., Agerholm, M., Vienberg, S. G., Gillum, M. P., Larsen, S., & Treebak, J. T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006756 · Cited by 45
Self-citationA Method to Monitor the NAD+ Metabolome—From Mechanistic to Clinical Applications
Giner, M. P., Christen, S., Bártová, S., Makarov, M. V., Migaud, M. E., Cantó, C., & Moco, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910598 · Cited by 39
“In comparison, NR led to a modest increase in NAD+ probably due to lower expression of NRK1 in this cell line [35,36].”
BackgroundSelf-citationThe emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism
Fletcher, R. S., & Lavery, G. G. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0085 · Cited by 38
van der Velpen, V., Rosenberg, N., Maillard, V., Teav, T., Chatton, J., Gallart‐Ayala, H., & Ivanisevic, J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15362 · Cited by 38
Role of PGC-1α in the Mitochondrial NAD+ Pool in Metabolic Diseases
Koh, J., & Kim, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094558 · Cited by 43
“NR can also be used as a precursor for NMN by NR kinase (NRK) in the salvage pathway [52].”
MethodNicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection
Sasaki, Y., Zhu, J., Shi, Y. Y., Gu, W., Kobe, B., Ve, T., DiAntonio, A., & Milbrandt, J. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113842 · Cited by 38
Fueling genome maintenance: On the versatile roles of NAD+ in preserving DNA integrity
Ruszkiewicz, J. A., Bürkle, A., & Mangerich, A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102037 · Cited by 44
“Besides, NMN can be produced during ATP-dependent phosphorylation of NR by nicotinamide riboside kinase (17), and cleavage of the NR glycosidic bond by purine nucleoside phosphorylase produces NAM.”
BackgroundHunt, N. J., Lockwood, G. P., Kang, S. W. S., Westwood, L. J., Limantoro, C., Chrzanowski, W., McCourt, P., Kuncic, Z., Couteur, D. G. L., & Cogger, V. C. (2021) · ACS Nano · doi:10.1021/acsnano.0c09278 · Cited by 39
Chen, Y., Yang, L., Lu, Y., Liu, N., Ma, W., Fan, H., Hu, Q., Han, X., Gan, W., & Li, D. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215689 · Cited by 35
Pyridine Dinucleotides from Molecules to Man
Fessel, J. P., & Oldham, W. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7120 · Cited by 38
“Supplementation with nicotinamide riboside and NMN relies on NRK activity (199).”
NAD+ and sirtuins in retinal degenerative diseases: A look at future therapies
Lin, J. B., & Apte, R. S. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.06.002 · Cited by 38
“However, this hypothesis is challenged by another school of thought that contends that extracellular NMN is first converted to NR before entering the cell (Nikiforov et al., 2011; Ratajczak et al., 2016).”
Degradation of Extracellular NAD+ Intermediates in Cultures of Human HEK293 Cells
Kulikova, V., Shabalin, K. A., Nerinovski, K., Yakimov, A. P., Svetlova, M., Solovjeva, L., Kropotov, A., Khodorkovskiy, M., Migaud, M. E., Ziegler, M., et al. (2019) · Metabolites · doi:10.3390/metabo9120293 · Cited by 39
“It is known that extracellular NAD+ and NMN can be degraded to the corresponding nucleoside, NR, which thereafter enters the cell as precursor for NAD synthesis [12,18].”
BackgroundResultSelf-citationDiscovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors
Wilsbacher, J. L., Cheng, M., Cheng, D., Trammell, S. A. J., Shi, Y., Guo, J. Q., Koeniger, S. L., Kovar, P. J., He, Y., Selvaraju, S., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0819 · Cited by 39
“Inhibition of PC3 cell viability by A-933414 was rescued by coincubation of cells with the product of NAMPT, NMN, which overcomes intracellular NAMPT inhibition by virtue of extracellular dephosphorylation to nicotinamide riboside and intracellular conversion to NADþ via the nicotinamide riboside kinase pathway (42).”
BackgroundSelf-citationTanamai, J., Veeramanomai, S., & Indrakosas, N. (2004) · PubMed · Cited by 43
Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging
Rahman, S. U., Qadeer, A., & Wu, Z. (2024) · Aging and disease · doi:10.14336/ad.2023.0519-1 · Cited by 34
Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases
Li, F., Wu, C., & Wang, G. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01072-3 · Cited by 39
“NR was then catalyzed to NMN inside cells by NRK to enter the NAD salvage synthesis pathways [117].”
MethodSyntheses and chemical properties of β-nicotinamide riboside and its analogues and derivatives
Makarov, M. V., & Migaud, M. E. (2019) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.15.36 · Cited by 33
Self-citationLuo, G., Xiao, L., Wang, D., Wang, N., Luo, C., Yang, X., & Hao, L. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.104808 · Cited by 35
Xu, W., Li, L., & Zhang, L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00901 · Cited by 35
“In addition, NMN can also be generated from another NAD+ precursor nicotinamide riboside (NR) by NR kinase 1/2 (NRK1/2) (Figures 1, 2).”
BackgroundInfluentialEffects of Chronic NAD Supplementation on Energy Metabolism and Diurnal Rhythm in Obese Mice
Roh, E., Kang, G. M., Gil, S. Y., Lee, C. H., Kim, S., Dugu, H., Son, G. H., & Kim, M. (2018) · Obesity · doi:10.1002/oby.22263 · Cited by 34
“22263 Funding agencies: This research was supported by grants from the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, and Future Planning (2013M3C7A1056024, 2015M3A9E7029177, 2017R1A2B3007123) and the Asan Institute for Life Science (17-326).”
BackgroundMethodInfluentialLin, Y., Wu, H., Wang, J., He, W., Hou, J., Martin, V. T., Zhu, C., Chen, Y., Zhong, J., Yu, B., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c01184 · Cited by 35
Signaling and Regulation Through the NAD + and NADP + Networks
Hassinen, I. E. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7479 · Cited by 33
“It is remarkable that NMN is metabolized extracellularly to NR, which is then taken up by the cells and converted into NAD + even in NRK1-KO animals (125).”
Cellular and Mitochondrial NAD Homeostasis in Health and Disease
Waddell, J., Khatoon, R., & Kristián, T. (2023) · Cells · doi:10.3390/cells12091329 · Cited by 34
“The NMN can also be formed by phosphorylation of nicotinamide riboside (NR) via NR kinase (NRK).”
BackgroundA metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder
Szot, J. O., Cuny, H., Martin, E. M. M. A., Sheng, D. Z., Iyer, K. R., Portelli, S., Nguyen, V., Gereis, J. M., Alankarage, D., Chitayat, D. A., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174824 · Cited by 35
“Oral NMN supplementation has been shown to safely increase NAD levels in humans (47) and, given its conversion to NR for cellular uptake (48), is expected to be equally as capable as NR of elevating NAD levels.”
BackgroundNAD+ precursor supplementation in human ageing: clinical evidence and challenges
Vinten, K. T., Trętowicz, M. M., Coskun, E., van Weeghel, M., Cantó, C., Perez, R. Z., Janssens, G. E., & Houtkooper, R. H. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01387-7 · Cited by 44
Self-citationMitochondrial Metabolism and Aging in Yeast
Baccolo, G., Stamerra, G., Pellegrino-Coppola, D., Orlandi, I., & Vai, M. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.001 · Cited by 39
Wei, X., Jia, R., Wang, G., Hong, S., Song, L., Sun, B., Chen, K., Wang, N., Wang, Q., Luo, X. M., et al. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108377 · Cited by 30
NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapies
Loreto, A., Antoniou, C., Merlini, E., Gilley, J., & Coleman, M. P. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.01.004 · Cited by 35
Braidy, N., Grant, R., & Sachdev, P. S. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000394 · Cited by 27
“Two NRK enzymes have been identified, NRK1 and NRK2; however, their exact physiological roles remain unclear [28].”
BackgroundNiacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma
Nomura, M., Ohuchi, M., Sakamoto, Y., Kudo, K., Yaku, K., Soga, T., Sugiura, Y., Morita, M., Hayashi, K., Miyahara, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43630-3 · Cited by 36
Biosynthesis of Nicotinamide Mononucleotide: Synthesis Method, Enzyme, and Biocatalytic System
Cheng, F., Li, K.-X., Wu, S., Liu, H., Li, H., Shen, Q., Xue, Y., & Zheng, Y. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c09217 · Cited by 27
Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide
Zheng, C., Li, Y., Wu, X., Gao, L., & Chen, X. (2024) · Nutrients · doi:10.3390/nu16142354 · Cited by 28
“On the other hand, the substrate of the NRK pathway, nicotinamide riboside, is also expensive and difficult to obtain, so its direct use as raw material is not feasible.”
BackgroundImai, S. (2025) · npj Aging · doi:10.1038/s41514-025-00192-6 · Cited by 31
Lu, Z., Jiang, L., Lesani, P., Zhang, W., Li, N., Luo, D., Li, Y., Ye, Y., Bian, J., Wang, G., et al. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac175 · Cited by 33
NAD+ Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease
Chanvillard, L., Tammaro, A., & Sorrentino, V. (2022) · Cells · doi:10.3390/cells12010021 · Cited by 29
“NRK1 is essential for the maintenance of energy homeostasis and catalyzes the ratelimiting step for the efficient utilization of exogenous NR and NMN [48].”
BackgroundHypothalamic NAD+-Sirtuin Axis: Function and Regulation
Roh, E., & Kim, M. (2020) · Biomolecules · doi:10.3390/biom10030396 · Cited by 30
“It has been proposed that NMN is converted to NR extracellularly by CD73 ecto-5′-nucleotidase [142] and then transported into cells via nucleoside transporters.”
BackgroundModulation of the cardiac sodium channel NaV1.5 peak and late currents by NAD+ precursors
Matasic, D. S., Yoon, J., McLendon, J. M., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.01.013 · Cited by 26
Self-citationPurine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells
Kropotov, A., Kulikova, V., Solovjeva, L., Yakimov, A. P., Nerinovski, K., Svetlova, M., Sudnitsyna, J. S., Plusnina, A., Antipova, M., Khodorkovskiy, M., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102615 · Cited by 31
“Our data are consistent with the observations of other researchers, according to which intraperitoneal injections of NR into mice at different doses (from 50 to 500 mg/kg) caused a significant accumulation of Nam in plasma and liver, while no significant accumulation of NR was observed (42, 46, 47).”
BackgroundResultSelf-citationNitrogen-15 dynamic nuclear polarization of nicotinamide derivatives in biocompatible solutions
Peters, J. P., Brahms, A., Janicaud, V., Anikeeva, M., Peschke, E., Ellermann, F., Ferrari, A., Hellmold, D., Held‐Feindt, J., Kim, N.-M., et al. (2023) · Science Advances · doi:10.1126/sciadv.add3643 · Cited by 25
Aryl hydrocarbon receptor (AHR) functions in NAD+ metabolism, myelopoiesis and obesity
Bock, K. W. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.02.021 · Cited by 27
Regulation of Cancer and Cancer-Related Genes via NAD +
Sharif, T., Martell, E., Dai, C., Ghassemi-Rad, M. S., Kennedy, B. E., Lee, P. W. K., & Gujar, S. A. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7478 · Cited by 27
“1), then metabolized via the classical salvage pathway as described above (16, 146).”
Zhang, X., Henneman, N. F., Girardot, P. E., Sellers, J. T., Chrenek, M. A., Li, Y., Wang, J., Brenner, C., Nickerson, J. M., & Boatright, J. H. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.10.47 · Cited by 27
Self-citationDeloux, R., Tannous, C., Ferry, A., Li, Z., & Mericskay, M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01290 · Cited by 28
NAD+-boosting molecules suppress mast cell degranulation and anaphylactic responses in mice
Kim, H.-W., Ryoo, G.-H., Jang, H., Rah, S., Lee, D. H., Kim, D., Bae, E. J., & Park, B. (2022) · Theranostics · doi:10.7150/thno.69684 · Cited by 27
“The intraperitoneal injection of NR (50 mg/kg or 500 mg/kg) led to beneficial outcomes in mice [24].”
BackgroundHarrison, R. L., Rowley, D. L., Mowery, J., et al. (2017) · Viruses · doi:10.3390/v9100307 · Cited by 24
“Cellular NRK1 is involved in the biosynthesis of nicotinamide adenine dinucleotide (NAD+) [38,39], but the function of the baculovirus NRK1 homologs is unclear.”
BackgroundExogenous nicotinamide adenine dinucleotide regulates energy metabolism via hypothalamic connexin 43
Roh, E., Park, J.-W., Kang, G. M., Lee, C. H., Dugu, H., Gil, S. Y., Song, D. K., Kim, H. J., Son, G. H., Yu, R., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.08.005 · Cited by 25
NAD+ metabolism and therapeutic strategies in cardiovascular diseases
Shi, C., Wen, Z., Yang, Y., Shi, L., & Liu, D. (2024) · Atherosclerosis Plus · doi:10.1016/j.athplu.2024.06.001 · Cited by 26
“It has been reported that more than 400 proteins are associated with NAD + metabolism [5,18 – 21].”
BackgroundBenjamin, C., & Crews, R. (2024) · Metabolites · doi:10.3390/metabo14060341 · Cited by 26
“Studies show that even when NR and NMN achieve similar increases in blood NAD+, their impact on different tissues and organs can diverge [22,48,49].”
BackgroundResultInfluentialSLC29A1 and SLC29A2 are human nicotinamide cell membrane transporters
Chen, M., Yuan, L., Chen, B., Chang, H., Luo, J., Zhang, H., Chen, Z., Kong, J., Yi, Y., Bai, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56402-y · Cited by 30
“ENT1/2 intervened in cellular senescence progress NAM 64 and its derivatives (NR 65 and NMN 66 ), common NAD+ booster, are believed to have an antiaging effect by regulating some NAD +-dependent antiaging enzymes.”
Nicotinamide mononucleotide ameliorates senescence in alveolar epithelial cells
Fang, T., Yang, H. J., Liu, L., Xiao, H., & Wei, X. (2021) · MedComm · doi:10.1002/mco2.62 · Cited by 22
The CD73 immune checkpoint promotes tumor cell metabolic fitness
Allard, D., Cousineau, I., Ma, E. H., Allard, B., Barèche, Y., Fleury, H., & Stagg, J. (2023) · eLife · doi:10.7554/elife.84508 · Cited by 28
“230 Moreover, the fact that NR supplementation restored intracellular NAD+ content in CD73231 deficient tumor cells, and that CD73 failed to increase NAD+ levels in the absence of NRK1 (since 232 NRK1 is necessary and rate-limiting for the generation of NAD+ from exogenous NR (17)), further 233 support the notion that…”
BackgroundHwang, D., Jo, H., Ma, S.-H., & Lim, Y. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.06.039 · Cited by 24
Oakey, L. A., Fletcher, R. S., Elhassan, Y., Cartwright, D. M., Doig, C. L., Garten, A., Thakker, A., Maddocks, O. D. K., Zhang, T., Tennant, D. A., et al. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14898.2 · Cited by 24
Nicotinamide Riboside Vitamin B3 Mitigated C26 Adenocarcinoma–Induced Cancer Cachexia
Park, J. M., Han, Y. M., Lee, H. J., Park, Y. J., & Hahm, K. B. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.665493 · Cited by 22
“Although not measured in this investigation, NRK1 is a rate-limiting enzyme for the use of exogenous NR for NAD+ synthesis (Ratajczak et al., 2016).”
BackgroundEnzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD
Sverkeli, L. J., Hayat, F., Migaud, M. E., & Ziegler, M. (2021) · Biomolecules · doi:10.3390/biom11071044 · Cited by 23
“NR enters the biosynthetic pathway through nicotinamide riboside kinases (NRKs), which convert NR to NMN in an ATP-dependent reaction [29,30], bypassing the rate-limiting step of the salvage pathway (Figure 1).”
BackgroundSelf-citationNAD+ Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis
Obrador, E., Palmer, R. S., López‐Blanch, R., Dellinger, R. W., & Estrela, J. M. (2021) · Biomedicines · doi:10.3390/biomedicines9081000 · Cited by 25
“Then, NR enters the cells through nucleoside transporters and can be re-phosphorylated back to NMN through the reaction catalyzed by NRK [59].”
BackgroundDhuguru, J., Dellinger, R. W., & Migaud, M. E. (2023) · Nutrients · doi:10.3390/nu15133064 · Cited by 26
Self-citationHill, L. J., & Williams, A. C. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917704662 · Cited by 26
Curran, C. S., & Kopp, J. B. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04584-8 · Cited by 22
“Inside the cell NR is transformed to NMN through an NR kinase [56].”
BackgroundNicotinamide Mononucleotide: Research Process in Cardiovascular Diseases
Deng, H., Ding, D., Ma, Y., Zhang, H., Wang, N., Zhang, C., & Yang, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179526 · Cited by 25
“NRK1 is a necessary and rate-limiting enzyme for the conversion of exogenous NMN to NAD + [18].”
BackgroundPathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells
Kolotyeva, N. A., Groshkov, A. A., Rozanova, N. A., Berdnikov, A. K., Novikova, S. V., Komleva, Y. K., Salmina, A. B., Illarioshkin, S. N., & Пирадов, М. А. (2024) · Biomolecules · doi:10.3390/biom14121556 · Cited by 24
“Nicotinamide riboside kinase 1 (NRK1) plays a role in regulating the metabolism of nicotinamide mononucleotide and nicotinamide riboside in cells [73,74].”
NAD + , Axonal Maintenance, and Neurological Disease
Alexandris, A. S., & Koliatsos, V. E. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0350 · Cited by 20
“Although the NRK pathway is not essential for intracellular NAD + salvage, it is indispensable for the utilization of extracellular NAD + pre-cursors such as NR and the membrane-impermeable NMN (Ratajczak et al., 2016) (Fig.”
BackgroundOverexpression of NRK1 ameliorates diet- and age-induced hepatic steatosis and insulin resistance
Fan, R., Cui, J., Ren, F., Wang, Q., Huang, Y., Zhao, B., Wei, L., Qian, X., & Xiong, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.107 · Cited by 21
Scalable syntheses of traceable ribosylated NAD + precursors
Makarov, M. V., Harris, N. W., Rodrigues, M. D. S., & Migaud, M. E. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob01981b · Cited by 20
Self-citationOakey, L. A., Fletcher, R. S., Elhassan, Y., Cartwright, D. M., Doig, C. L., Garten, A., Thakker, A., Maddocks, O. D. K., Zhang, T., Tennant, D. A., et al. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14898.1 · Cited by 20
Kitaoka, Y., Sase, K., Tsukahara, C., Fujita, N., Arizono, I., & Takagi, H. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02063-5 · Cited by 19
Quantitation of NAD+: Why do we need to measure it?
Liu, Y., Clement, J., Grant, R., Sachdev, P. S., & Braidy, N. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.07.023 · Cited by 22
Technology and functional insights into the nicotinamide mononucleotide for human health
Liu, Y., Gong, J., Marshall, G., Su, C., Shi, J., & Xu, Z. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12612-2 · Cited by 19
“In humans, there exists two forms: NRK1 and NRK2, in which the amino acid sequence is highly conserved (Khan et al. 2007; Ratajczak et al. 2016).”
BackgroundTriple-Isotope Tracing for Pathway Discernment of NMN-Induced NAD+ Biosynthesis in Whole Mice
Sauve, A. A., Wang, Q., Zhang, N., Kang, S., Rathmann, A., & Yang, Y. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311114 · Cited by 19
“The majority of NAD+ synthesis following oral intake of NR or NMN has been attributed to the breakdown of these precursors to nicotinamide, which is then salvaged via nicotinamide phosphoribosyltransferase (Nampt) to form NMN and later converted to NAD+ via the actions of adenylyltransferases (Nmnat1,2,3) [6,7,21].”
BackgroundInfluentialPotential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19
Bogan-Brown, K. L., Nkrumah-Elie, Y. M., Ishtiaq, Y., Redpath, P., & Shao, A. E. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.1881686 · Cited by 22
“For NR, the rate limiting step for conversion to NADþ is phosphorylation by NRK, the expression of which (NRK1) is relatively high in kidney and liver (Ratajczak et al. 2016).”
BackgroundSelf-citationSIRT1-dependent restoration of NAD+ homeostasis after increased extracellular NAD+ exposure
Buonvicino, D., Ranieri, G., Pittelli, M. G., Lapucci, A., Bragliola, S., & Chiarugi, A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100855 · Cited by 17
Ryu, W., Shen, M., Lee, Y., Healy, R. A., Bormann, M. K., Cohen, B. M., & Sonntag, K. (2022) · Aging Cell · doi:10.1111/acel.13658 · Cited by 18
“It is converted to NMN by NR kinase 1 (NRK1), then processed to the NAD precursor nicotinic acid adenine dinucleotide (NAAD) by NMNAT1, 2, or 3 (Figure 1a) (Bieganowski & Brenner, 2004; Ratajczak et al., 2016).”
MethodCheng, F., Wu, X., Li, H., Li, K.-X., Guo, Q., Shen, Q., Xue, Y., & Zheng, Y. (2023) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.3c02833 · Cited by 18
Sobriety and Satiety: Is NAD+ the Answer?
Braidy, N., Villalva, M. D., & van Eeden, S. (2020) · Antioxidants · doi:10.3390/antiox9050425 · Cited by 18
“Dephosphorylation of NMN into NR, which is required to produce NAD+ in yeast, represents a crucial step for increasing intracellular NAD+ in mammalian cells [160].”
BackgroundXue, Y., Shamp, T., Gowda, G. A. N., Crabtree, M., Bagchi, D., & Raftery, D. (2022) · Nutrients · doi:10.3390/nu14112219 · Cited by 19
“It was demonstrated that supplementation of NR increases NAD+ levels, enhances oxidative metabolism, and reduces fat and hepatic steatosis [17,18].”
BackgroundMethodLuo, S., Zhao, J., Zheng, Y., Chen, T., & Wang, Z. (2023) · Fermentation · doi:10.3390/fermentation9070594 · Cited by 20
Reply to: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter
Grozio, A., Mills, K. F., Yoshino, J., Bruzzone, S., Sociali, G., Tokizane, K., Lei, H. C., Sasaki, Y., Migaud, M. E., & Imai, S. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0086-z · Cited by 16
Self-citationTIR immune signalling is blocked by phosphorylation to maintain plant growth
Li, G., Chen, S., Yu, B., Li, Q., Liu, R., Wang, Z., Wan, L., & Zhao, Y. (2025) · Nature Plants · doi:10.1038/s41477-025-02012-x · Cited by 20
“Nicotinamide Ribo-side Kinase 1 (NRK1) drives NAD + biosynthesis from NAD + precursors such as nicotinamide riboside in mammalian cells, which alleviates SARM1-mediated NAD + depletion 3,47 .”
Cheng, Y., Zhao, J., Zong, W., Wei, X.-J., Xu, Z., Yuan, Y., Jiang, Y.-F., Luo, X., Wang, W., & Qu, W. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03610-3 · Cited by 16
Zhan, J., Huang, L., Niu, L., Lu, W., Sun, C., Liu, S., Ding, Z., & Li, E. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01755-y · Cited by 24
“The intracellular NR is then phosphorylated to NMN by nicotinamide riboside kinase 1 (NRK1) [35].”
BackgroundBai, L., Yau, L., Tong, T., Chan, W.-H., Zhang, W., & Jiang, Z. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.986 · Cited by 14
Chemo-enzymatic synthesis of isotopically labeled nicotinamide riboside
Tran, A., Yokose, R., & Cen, Y. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob00552d · Cited by 14
Gaudino, F., Manfredonia, I., Managò, A., Audrito, V., Raffaelli, N., Vaisitti, T., & Deaglio, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7799 · Cited by 16
“NR is an additional salvageable NAD + precursor via the NRKs-mediated pathway.”
InfluentialNAD + metabolism and function in innate and adaptive immune cells
Mann, R., Stavrou, V., & Dimeloe, S. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00457-7 · Cited by 24
“NAD + also acts as a co-substrate for many enzymes, through which NAD + is pathway [5, 6].”
Sonntag, T., Ancel, S., Karaz, S., Cichosz, P., Jacot, G. E., Giner, M. P., Sanchez-Garcia, J. L., Pannérec, A., Moco, S., Sorrentino, V., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1049653 · Cited by 18
“…muscle NAD+ production relies on the salvage of intracellular NAD+ metabolites as well as dietary vitamin B3 precursors such as niacin, nicotinamide (NAM), nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) (Frederick et al., 2016; Ratajczak et al., 2016; Fletcher et al., 2017).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Ratajczak, J., Joffraud, M., Trammell, S. A. J., Ras, R., Canela, N., Boutant, M., Kulkarni, S. S., Rodrigues, M., Redpath, P., Migaud, M. E., Auwerx, J., Yanes, O., Brenner, C., & Cantó, C.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- University of Iowa (US)
- Centre for Omic Sciences (ES)
- Queen's University Belfast (GB)
- Corresponding author
- Brenner, Charles
- Cantó, Carles
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-11
- Volume
- 7
- Issue
- 1
- Pages
- 13103-13103
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5476803
- OpenAlex
- W2531686927
- Cited by
- 378
- References
- 46
- Citations by year
- 2026: 34 · 2025: 35 · 2024: 48 · 2023: 46 · 2022: 38 · 2021: 40 · 2020: 31 · 2019: 43 · 2018: 28 · 2017: 31 · 2016: 2
- FWCI
- 19.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Roy J. Carver Charitable Trust
- École Polytechnique Fédérale de Lausanne
- National Institutes of Health
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/N001842/1)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Heart, Lung, and Blood Institute (R01HL108379)
- National Institute of General Medical Sciences (T32GM008629)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Keywords
- nicotinamide mononucleotide, nicotinamide riboside, NAD+ synthesis, NAD+ precursors, sirtuins, poly(ADP-ribose) polymerase, NAD+ supplementation
- MeSH terms
- Animals, Humans, Injections, Intraperitoneal, Mammals, NAD, Niacinamide, Nicotinamide Mononucleotide, Pyridinium Compounds, Phosphotransferases (Alcohol Group Acceptor), Mice, Knockout, Hepatocytes, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.